Koyfin Home > Directory > Health Care > Amedisys Inc > Gross Margin

Amedisys Inc Gross Margin Chart (AMED)

Amedisys Inc annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Amedisys Inc Gross Margin for the quarter ending June 06, 2020 was $43m a 2.84% increase of 1m year over year
  • Amedisys Inc Gross Margin for the last 12 months ending June 06, 2020 was $42m a 2.37% increase of 1m year over year
  • Amedisys Inc Annual Gross Margin for 2019 was $41m a 2.18% increase of 1m from 2018
  • Amedisys Inc Annual Gross Margin for 2018 was $40m a 0.14% increase of 0m from 2017
  • Amedisys Inc Annual Gross Margin for 2017 was $40m a -2.45% decrease of -1m from 2016
Other Margins & Efficiency Metrics:
  • Amedisys Inc EBITDA Margin for the quarter ending December 12, 2018 was $9m a -8.23% decrease of -1m year over year
  • Amedisys Inc Return on Capital % for the quarter ending December 12, 2018 was 18.37 a 18.84% increase of 3.46 year over year
  • Amedisys Inc Return on Equity % for the quarter ending December 12, 2018 was 23.89 a 14.19% increase of 3.39 year over year
View Chart On Koyfin

Quarterly AMED Gross Margin Data

06/2020$43m
03/2020$42m
12/2019$41m
09/2019$42m
06/2019$41m
03/2019$41m
12/2018$40m
09/2018$40m
06/2018$41m
03/2018$40m

Annual AMED Gross Margin Data

2019$41m
2018$40m
2017$40m
2016$41m
2015$43m
2014$42m
2013$42m
2012$43m
2011$47m
2010$50m